COOPER FINANCIAL GROUP – Edwards Lifesciences Corporation Transaction History
COOPER FINANCIAL GROUP portfolio value:
$305,000
portfolio value
COOPER FINANCIAL GROUP quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.20% | -83 shares | -54K | $82.63 | 3.69K |
| Q2 2022 | share | Increase | +2.36% | 87 shares | -75K | $95.09 | 3.77K |
| Q1 2022 | share | 0.00% | 0 shares | -44K | $117.72 | 3.69K | |
| Q4 2021 | share | Decrease | -16.95% | -753 shares | -25K | $130.68 | 3.69K |
| Q3 2021 | share | 0.00% | 0 shares | 43K | $113.21 | 4.44K | |
| Q2 2021 | share | Increase | +17.54% | 663 shares | 144K | $103.57 | 4.44K |
| Q1 2021 | share | 0.00% | 0 shares | -29K | $83.64 | 3.78K | |
| Q4 2020 | share | Increase | +8.31% | 290 shares | 66K | $91.23 | 3.78K |
| Q3 2020 | share | Decrease | -17.47% | -739 shares | -13K | $79.82 | 3.49K |
| Q2 2020 | share | Increase | 0.00% | 4.22K shares | 292K | $69.11 | 4.22K |
| Q1 2020 | share | Decrease | -100.00% | -3.90K shares | -304K | $62.87 | 0 |
| Q4 2019 | share | Increase | +0.46% | 18 shares | 19K | $77.76 | 3.90K |
| Q3 2019 | share | Increase | +7.73% | 279 shares | 63K | $73.3 | 3.88K |
| Q2 2019 | share | 0.00% | 0 shares | -8K | $61.58 | 3.60K | |
| Q1 2019 | share | Increase | 0.00% | 3.60K shares | 230K | $63.78 | 3.60K |